The phenomenon of immune sensitisation following IFNγ-signalling ablation is not restricted to B16F10 melanoma, as other groups have reported similar findings in mammary, colon, pancreatic and lung tumour models in both Balb/c and C57Bl/6 animals23,54,55. This evidence concerns the gene IFNG and melanoma.